{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:28Z","timestamp":1791849388708,"version":"4.3.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10072-026-09313-9","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T01:07:13Z","timestamp":1787188033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nilotinib-associated cerebral vasculopathy: temporal shifts in vascular involvement by treatment duration"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-1878","authenticated-orcid":false,"given":"Jong-Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"2","key":"9313_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1161\/ATVBAHA.119.313353","volume":"40","author":"A Manouchehri","year":"2020","unstructured":"Manouchehri A, Kanu E, Mauro MJ, Aday AW, Lindner JR, Moslehi J (2020) Tyrosine kinase inhibitors in leukemia and cardiovascular events: from mechanism to patient care. Arterioscler Thromb Vasc Biol 40(2):301\u2013308","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"9313_CR2","first-page":"239","volume":"10","author":"K Suzuki","year":"2019","unstructured":"Suzuki K, Yamamoto J, Kakeda S, Takamatsu S, Miyaoka R, Kitagawa T, Saito T, Nakano Y, Nishizawa S (2019) Vessel wall magnetic resonance imaging findings and surgical treatment in nilotinib-associated cerebrovascular disease: a case report. Mol Clin Oncol 10(2):239\u2013243","journal-title":"Mol Clin Oncol"},{"issue":"8","key":"9313_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105883","volume":"30","author":"B Kakadia","year":"2021","unstructured":"Kakadia B, Thakkar R, Sanborn E, Suero-Abreu GA, Jovin TG, Then R (2021) Nilotinib-associated atherosclerosis presenting as multifocal intracranial stenosis and acute stroke. J Stroke Cerebrovasc Dis 30(8):105883","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9313_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2176\/jns-nmc.2022-0298","volume":"10","author":"Y Rai","year":"2023","unstructured":"Rai Y, Hara T (2023) Tyrosine kinase inhibitor-associated cerebral arterial occlusive disease treated with high-flow bypass surgery: a case report. NMC Case Rep J 10:61\u201366","journal-title":"NMC Case Rep J"},{"issue":"1","key":"9313_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12883-024-04006-2","volume":"25","author":"N Sasaki","year":"2025","unstructured":"Sasaki N, Enomoto Y, Hori T, Matsubara H, Egashira Y, Izumo T (2025) Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases. BMC Neurol 25(1):6","journal-title":"BMC Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09313-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09313-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09313-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:33:12Z","timestamp":1791847992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09313-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9313"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09313-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case was approved with a waiver of informed consent by the Institutional Review Board of Eunpyeong St. Mary\u2019s Hospital (IRB No. PC26ZESI0081).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no potential conflicts of interest to disclose.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"721"}}